Monte Rosa Therapeutics (GLUE) said Monday that it entered into a global development and commercialization license agreement with Novartis (NVS) for VAV1-directed molecular glue degraders, including MRT-6160.
Shares of Monte Rosa soared 140% as intraday trading volume catapulted to over 83.7 million from a daily average of more than 349,000.
Autonomix Medical (AMIX) said Monday three patients responded to its radio frequency pain management with femoral access in an ongoing clinical trial evaluating its potential to manage pain in pancreatic cancer patients without the use of opioids.
Shares surged 71% as intraday trading volume climbed to more than 17.7 million, versus a daily average of over 20,000.
Porch Group (PRCH) said Monday the Texas Department of Insurance approved its application to form and license a new insurance reciprocal exchange.
Shares jumped nearly 80%, with intraday trading volume at over 14.5 million compared with a daily average of more than 846,000.
Price: 11.86, Change: +6.97, Percent Change: +142.54
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。